decoding her2 in nsclc: advances in biomarker testing and targeted therapies
Published 3 months ago • 73 plays • Length 36:45Download video MP4
Download video MP3
Similar videos
-
33:28
novel targeted therapies for nsclc: exploring her2 dysregulation
-
23:25
advanced nsclc: advances in biomarker testing and immunotherapy
-
3:33
current recommendations and best practices for biomarker testing - targeted therapies in lung cancer
-
36:48
personalized therapy for nsclc: biomarker testing, treatment & management in met alterations
-
5:50
how is biomarker testing carried out?
-
40:57
expanding her2 horizons: implications for nsclc and beyond
-
37:25
personalized therapy for nsclc: biomarker testing, treatment and management in met alterations
-
37:44
deciphering the data in egfr - mutant nsclc
-
11:47
petscan results. warning...not what we hoped for.
-
5:41
understanding nsclc treatments for less common mutations: alk, braf, ros1, her2, met
-
2:25
warning signs of lymphoma
-
58:27
addressing key targets in advanced nsclc: her2-, her3-, and trop2-targeted therapies
-
1:04:49
everything you need to know about molecular testing and targeted therapies in nsclc
-
1:24:29
optimizing advanced nsclc biomarker testing, treatment and management session 2
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
4:35
the importance of biomarker testing: what is liquid biopsy? - targeted therapies in lung cancer 2023
-
1:45
strategies to target her2 in lung cancer
-
4:18
when should biomarker testing be done in nsclc?
-
7:18
navigating nsclc: merging molecular insights and targeted therapy | biomarker-guided therapy in n...
-
6:37
8 in 8 series: biomarker testing and neoadjuvant immunotherapy for resectable nsclc
-
1:13
challenges to targeting her2 in lung cancer
-
10:28
candid conversations in lung cancer: discussing biomarker testing and targeted therapies